Understanding Ketamine Therapy Beyond the Headlines

If you have heard about ketamine therapy, there is a good chance the information came with a dramatic headline. Some stories describe it as a groundbreaking treatment for depression. Others focus on ketamine’s history as an anesthetic or its misuse outside medical settings. With so many different messages circulating, it can be difficult to understand what ketamine-based treatment actually involves and whether it has a legitimate place in mental health care.

The truth is more thoughtful than either extreme. Ketamine is not a miracle cure, but it is also not simply a passing trend. Research has shown that ketamine and medications derived from it may provide meaningful relief for certain people, particularly those living with depression that has not improved after trying more traditional treatments.

Understanding the facts can help you approach the conversation with realistic expectations and better questions.

What Is Ketamine?

Ketamine is a medication that has been used as an anesthetic for decades. In medical settings, it has an established role in anesthesia and pain management. Over time, researchers began noticing that lower doses of ketamine appeared to have rapid effects on depressive symptoms in some patients.

This discovery led to growing interest in ketamine therapy for mental health conditions, especially treatment-resistant depression. Treatment-resistant depression generally refers to depression that has not improved enough after a person has tried multiple appropriate treatments.

Ketamine works differently from many traditional antidepressants. Most conventional antidepressants primarily affect neurotransmitters such as serotonin, norepinephrine, or dopamine. Ketamine interacts with the brain’s glutamate system, which is involved in communication between brain cells, learning, memory, and neuroplasticity.

Researchers are still studying exactly how these changes translate into symptom relief. What is clear is that ketamine has opened a new direction in the study and treatment of depression.

Ketamine and Spravato Are Related, but They Are Not the Same

One of the most common sources of confusion is the difference between ketamine and Spravato.

Ketamine contains two mirror-image molecular forms. Esketamine is one of those forms. Spravato is the brand name for an FDA-approved nasal spray containing esketamine.

Traditional ketamine may be administered in several ways, including through an intravenous infusion or intramuscular injection. When ketamine is prescribed for a psychiatric condition, that use is generally considered “off-label.” This means the medication itself is approved by the FDA, but not specifically approved in that form for treating a mental health condition.

Spravato, on the other hand, has received FDA approval for specific depression-related indications. It is administered in a certified clinical setting where patients are monitored after receiving the medication.

These distinctions matter. Although the terms are sometimes used interchangeably in casual conversation, ketamine and esketamine have different formulations, approval statuses, administration requirements, and treatment protocols.

Myth: Ketamine Therapy Is a Recreational Experience Disguised as Treatment

Ketamine has been misused recreationally, which can make people understandably cautious. However, medically supervised treatment is very different from taking an unknown substance without professional oversight.

In a clinical setting, the medication comes from a regulated source and is given according to a carefully considered treatment plan. A healthcare professional reviews the patient’s medical history, current medications, symptoms, previous treatments, and potential risk factors before determining whether treatment may be appropriate.

Patients are also monitored for changes in blood pressure, sedation, dissociation, and other possible reactions. The purpose is not to create an escape from reality. The goal is to safely address symptoms as part of a broader psychiatric treatment plan.

Myth: Ketamine Is a Cure for Depression

The word “breakthrough” can sometimes make a treatment sound like a guaranteed cure. Ketamine-based treatment can be meaningful for some patients, but it does not work for everyone. Even when a person responds well, the improvement may not be permanent after a single treatment.

Some people receive a structured series of treatments followed by maintenance care. Others may combine treatment with psychiatric medication management, psychotherapy, lifestyle support, or another evidence-based intervention.

Response times also vary. One person may notice a shift relatively quickly, while another may experience gradual improvement or no significant benefit. A responsible provider should discuss these possibilities before treatment begins rather than promising a particular result.

Mental health recovery is rarely built around one medication alone. It is usually a process of finding the right combination of care for the individual.

Myth: Ketamine Therapy Is Only for People in an Immediate Crisis

Ketamine and esketamine have received attention because of their potential to act more quickly than conventional antidepressants. This can be especially significant when depressive symptoms are severe. However, that does not mean these treatments are only considered during a crisis.

A provider may evaluate ketamine-derived treatment when someone has experienced ongoing depression despite trying multiple medications or other therapies. The decision is based on diagnosis, treatment history, overall health, risks, and the provider’s clinical judgment.

Ketamine-based care is not a substitute for emergency support. Anyone who is in immediate danger or considering suicide should call or text 988, call 911, or go to the nearest emergency department.

What Does Treatment Feel Like?

Experiences can vary, but some people report feeling temporarily detached from their surroundings, unusually calm, lightheaded, sleepy, or as though their perception of time has shifted. These effects are sometimes described as dissociation.

Other possible short-term effects can include nausea, dizziness, anxiety, changes in blood pressure, or temporary difficulty concentrating. This is one reason treatment should take place with appropriate medical supervision.

With in-clinic esketamine treatment, patients remain at the clinic for an observation period after receiving the medication. They should also plan for transportation because they cannot drive themselves home after treatment.

A qualified provider will explain what to expect before the first appointment, including how to

prepare, how long the visit may take, what monitoring is involved, and what activities should be avoided afterward.

Who May Not Be a Good Candidate?

Ketamine-based treatment is not automatically appropriate for every person with depression. Certain cardiovascular conditions, substance-use concerns, pregnancy, a history of psychosis, uncontrolled high blood pressure, and other health factors may affect whether it can be used safely.

This does not always mean someone is permanently excluded. It means that an individualized medical evaluation is essential.

Patients should tell their provider about all medications, supplements, health conditions, past reactions to anesthesia, and substance-use history. Honest conversations allow the clinical team to evaluate risks and recommend the safest available options.

What Should You Ask a Provider?

If you are considering treatment, it is reasonable to ask detailed questions. You may want to discuss:

• Which treatment is being offered: ketamine, esketamine, or Spravato?

• Is this treatment FDA-approved for my diagnosis?

• Why might I be a suitable candidate?

• What benefits and side effects should I realistically expect?

• How will I be monitored during and after each appointment?

• How many sessions are typically included in the initial treatment plan?

• How will we determine whether it is helping?

• What happens if my symptoms return?

• How will this treatment work alongside my current medications or therapy?

• What costs may be covered by insurance?

A trustworthy provider should be willing to answer these questions without pressuring you to make an immediate decision.

Looking Beyond the Headlines

The growing conversation around ketamine reflects something important: people living with difficult-to-treat depression need more options. At the same time, hope should be paired with careful evaluation, accurate information, and realistic expectations.

Ketamine-based treatments can offer a different path for some patients, particularly when traditional approaches have not provided enough relief. They still require medical screening, professional monitoring, follow-up care, and an individualized treatment plan.

If you are curious about ketamine therapy or want to understand whether a related treatment such as Spravato may be appropriate, the next step is not to rely on a headline or someone else’s experience. It is to speak with a qualified psychiatric provider who can help you consider the potential benefits and risks in the context of your own health.

Goodwin Health Cafe provides individualized, evidence-informed psychiatric care in a calming and nonjudgmental environment. Visit us at 5625 N. Wall St. Suite 100, Spokane, WA 99205 to learn more about available treatment options.